Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1982;4:125-131

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by de Leeuw, P. W.
Right arrow Articles by Birkenhager, W. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by de Leeuw, P. W.
Right arrow Articles by Birkenhager, W. H.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*High Blood Pressure
Hazardous Substances DB
*PROPRANOLOL HYDROCHLORIDE

Hypertension, Vol 4, 125-131, Copyright © 1982 by American Heart Association


ARTICLES

Renal response to propranolol treatment in hypertensive humans

PW de Leeuw and WH Birkenhager

To investigate the relationship between sympathetic activity and blood flow in the kidney during propranolol treatment, 55 patients with uncomplicated essential hypertension were studied. Twenty-five of them had been treated with propranolol (average daily dose 240 mg) for about two weeks; the others served as untreated controls. In all patients renal arteriography was carried out, after which renal plasma flow (125I-hippuran clearance), cortical blood flow (xenon-washout), and renal release of norepinephrine and renin were measured. In the propranolol group, renal plasma flow had also been determined before treatment. Cardiac output (dye-dilution) and creatinine clearance were measured both before as well as during therapy. In untreated hypertensives renal cortical blood flow was reduced to about 80% of what was predicted for the age level. On the basis of their changes in blood pressure, patients who were treated with propranolol were divided into responders (n = 15) and nonresponders (n = 10). Despite a similar fall in cardiac output in both subgroups, renal blood flow remained unchanged in responders, while it fell in nonresponders. In addition, renal norepinephrine release was significantly higher in nonresponders than in responders, while renin release in nonresponders was markedly suppressed. It may be concluded that sympathetic activity is an important determinant of renal (cortical) blood flow in essential hypertension. The effect of propranolol on the renal circulation depends, to some extent, on its unmasking of prevailing alpha- adrenergic tone. However, when blood pressure falls, an additional mechanism may be operative to cause renal vasodilation.


This article has been cited by other articles:


Home page
Arch Intern MedHome page
S. C. Textor, A. C. Novick, D. R. Steinmuller, and S. B. Streem
Renal Failure Limiting Antihypertensive Therapy as an Indication for Renal Revascularization: A Case Report
Arch Intern Med, November 1, 1983; 143(11): 2208 - 2211.
[Abstract] [PDF]